RK

Rahul Kumar Peraka

Active Director Director DIN 09064660
DIN 09064660 First appointment Feb 2021 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Feb 2021
Shareholding value •••• Premium profile

About Rahul Kumar Peraka

Data last updated:

Rahul Kumar Peraka is a Director at Lorven Biologics Private Limited (since 2021), Director at Srk Cleanrooms Private Limited (since 2021) and Director at Lorven Pathlabs Private Limited (since 2025). The companies operate in Life Sciences, Business Services and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹17.13 Cr; the largest is Lorven Biologics Private Limited at ₹11.28 Cr (FY 2023). Earlier, Rahul Kumar Peraka was an Additional Director at Lorven Therapeutics Private Limited (2021–2025) and Director at Seyn Biologics Private Limited (2023–2024) and 1 more.

DIN 09064660
Primary Designation Director
Industry Life Sciences
First Appointment 11 Feb 2021
Oldest Company Age 11 yrs
Largest company Lorven Biologics Private Limited · ₹11.28 Cr (FY 2023)
Combined revenue ₹17.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lorven Biologics Private Limited U74120AP2015PTC097532
Director01 Mar 20212015₹11.28 Cr (FY 2023)Active
Srk Cleanrooms Private Limited U36900TG2021PTC148625
Director11 Feb 20212021₹5.85 Cr (FY 2025)Active
Lorven Pathlabs Private Limited U21000TS2025PTC204879
Director08 Oct 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lorven Therapeutics Private Limited U24110AP2017PTC106873
Additional Director01 Oct 20212017₹24.3 Lakh (FY 2023)Active
Seyn Biologics Private Limited U21001TS2023PTC177390
Director22 Sep 20232023Active
Director11 Jan 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rahul Kumar Peraka

Directorship timeline

Open interactive timeline →
Srh Prefab Industries Private Limited
Srk Cleanrooms Private Limited
Lorven Biologics Private Limited
Lorven Pathlabs Private Limited
Premium access

Shareholding and investment profile for Rahul Kumar Peraka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Kumar Peraka

Rahul Kumar Peraka currently holds 3 directorships: Lorven Biologics Private Limited (Director, since 01 Mar 2021, revenue ₹11.28 Cr (FY 2023)); Srk Cleanrooms Private Limited (Director, since 11 Feb 2021, revenue ₹5.85 Cr (FY 2025)); Lorven Pathlabs Private Limited (Director, since 08 Oct 2025).

Rahul Kumar Peraka was first appointed on 11 Feb 2021 as Director at Srk Cleanrooms Private Limited. The most recent appointment on record is 08 Oct 2025 at Lorven Pathlabs Private Limited.

The 2 current companies of Rahul Kumar Peraka that report revenue have a combined latest revenue of ₹17.13 Cr: Lorven Biologics Private Limited ₹11.28 Cr (FY 2023); Srk Cleanrooms Private Limited ₹5.85 Cr (FY 2025).

Rahul Kumar Peraka held 3 earlier board appointments: Lorven Therapeutics Private Limited (Additional Director, 01 Oct 2021 to 31 Mar 2025); Seyn Biologics Private Limited (Director, 22 Sep 2023 to 02 Jul 2024); Srh Prefab Industries Private Limited (Director, from 11 Jan 2022).

The current boards of Rahul Kumar Peraka's companies include Srikanth Reddy Devireddy (Lorven Biologics Private Limited), Venkataramana Mudili (Lorven Biologics Private Limited), Munigonda Mallesh (Srk Cleanrooms Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available